Literature DB >> 6643650

Clinical, laboratory, and genetic investigations of hypophosphatasia: support for autosomal dominant inheritance with homozygous lethality.

J R Eastman, D Bixler.   

Abstract

This article presents detailed clinical and laboratory investigations of six hypophosphatasia kindreds. Serum alkaline phosphatase and urinary phosphoethanolamine comparisons between the affected population and a normal control population demonstrate these parameters routinely identify the heterozygous individual when age and sex variations are accounted for. Using clinical data from the kindred population and a detailed review of the literature, the type and frequency of clinical findings for both the homozygous and heterozygous genotype are enumerated. The clinical and biochemical phenotypes were subjected to segregation analysis. When the results of these analyses are viewed in light of their mathematical limitations and the genetic precepts of autosomal dominant and recessive inheritance, hypophosphatasia is best described as an autosomal dominant disorder with 85% penetrance and homozygous lethality.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6643650

Source DB:  PubMed          Journal:  J Craniofac Genet Dev Biol        ISSN: 0270-4145


  8 in total

1.  Computer assisted analysis of hand radiographs in infantile hypophosphatasia carriers.

Authors:  B N Chodirker; D Roy; C R Greenberg; M Cheang; J A Evans; M H Reed
Journal:  Pediatr Radiol       Date:  1991

2.  Clinical utility gene card for: hypophosphatasia.

Authors:  Etienne Mornet; Christine Beck; Agnès Bloch-Zupan; Hermann Girschick; Martine Le Merrer
Journal:  Eur J Hum Genet       Date:  2010-10-27       Impact factor: 4.246

3.  Clinical utility gene card for: hypophosphatasia - update 2013.

Authors:  Etienne Mornet; Christine Hofmann; Agnès Bloch-Zupan; Hermann Girschick; Martine Le Merrer
Journal:  Eur J Hum Genet       Date:  2013-08-07       Impact factor: 4.246

4.  Genetic analysis of adults heterozygous for ALPL mutations.

Authors:  Agnès Taillandier; Christelle Domingues; Annika Dufour; Françoise Debiais; Pascal Guggenbuhl; Christian Roux; Catherine Cormier; Bernard Cortet; Valérie Porquet-Bordes; Fabienne Coury; David Geneviève; Jean Chiesa; Thierry Colin; Elaine Fletcher; Agnès Guichet; Rose-Marie Javier; Michel Laroche; Michael Laurent; Ekkehart Lausch; Bruno LeHeup; Cédric Lukas; Georg Schwabe; Ineke van der Burgt; Christine Muti; Brigitte Simon-Bouy; Etienne Mornet
Journal:  J Bone Miner Metab       Date:  2017-12-13       Impact factor: 2.626

5.  Alkaline phosphatase: placental and tissue-nonspecific isoenzymes hydrolyze phosphoethanolamine, inorganic pyrophosphate, and pyridoxal 5'-phosphate. Substrate accumulation in carriers of hypophosphatasia corrects during pregnancy.

Authors:  M P Whyte; M Landt; L M Ryan; R A Mulivor; P S Henthorn; K N Fedde; J D Mahuren; S P Coburn
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

6.  Hyperphosphatemia in infantile hypophosphatasia: implications for carrier diagnosis and screening.

Authors:  B N Chodirker; J A Evans; L E Seargeant; M S Cheang; C R Greenberg
Journal:  Am J Hum Genet       Date:  1990-02       Impact factor: 11.025

Review 7.  Hypophosphatasia.

Authors:  Etienne Mornet
Journal:  Orphanet J Rare Dis       Date:  2007-10-04       Impact factor: 4.123

8.  Mild forms of hypophosphatasia mostly result from dominant negative effect of severe alleles or from compound heterozygosity for severe and moderate alleles.

Authors:  Delphine Fauvert; Isabelle Brun-Heath; Anne-Sophie Lia-Baldini; Linda Bellazi; Agnès Taillandier; Jean-Louis Serre; Philippe de Mazancourt; Etienne Mornet
Journal:  BMC Med Genet       Date:  2009-06-06       Impact factor: 2.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.